COVID-19疫苗接种在18F-FDG PET/CT上表现为偶发淋巴结摄取
本文报告一例86岁女性鼻部黑色素瘤治疗后随访病例,在第二剂Pfizer-BioNTech COVID-19疫苗(左三角肌注射)后第6天行18F-FDG PET,显示左三角肌及2枚左胸肌下正常大小淋巴结摄取增高,考虑为疫苗接种所致。作者强调扫描时记录疫苗接种史对避免假阳性结果的重要性。
要点
- 疫苗接种后可出现注射侧三角肌及区域淋巴结FDG摄取增高
- 扫描时应记录疫苗接种史以减少假阳性判读
- 该例为个案报告,结论需结合临床背景判断
核心结论
- 疫苗接种可导致注射部位及区域淋巴结18F-FDG摄取增高,属于良性反应性改变,需与肿瘤转移鉴别。
研究设计与样本
- 个案报告:1例86岁女性鼻部黑色素瘤治疗后随访患者,于第二剂Pfizer-BioNTech COVID-19疫苗(左三角肌注射)后第6天行18F-FDG PET/CT。
主要发现
- 18F-FDG PET显示左三角肌及2枚左胸肌下正常大小淋巴结示踪剂摄取增高,考虑为疫苗接种继发改变。
关键数值与推荐
- 原文未报告具体SUV值、阈值或统计学指标。
临床怎么用
- 扫描时应记录疫苗接种史及注射部位,结合摄取分布特点将注射侧三角肌及区域淋巴结反应性摄取判为良性,避免误判为转移。
局限性
- 仅为单例个案报告,缺乏系统样本量与随访验证,结论推广受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Benign uptake on 18F-FDG PET can be seen with inflammatory conditions. We report a case of an 86-year-old woman with successfully treated nasal melanoma who underwent routine follow-up 18F-FDG PET, day 6 after the second dose of Pfizer-BioNTech COVID-19 vaccine inoculated in the left deltoid muscle. 18F-FDG PET showed increase tracer uptake in the left deltoid muscle and in 2 normal-sized left subpectoral nodes. These findings were considered secondary to vaccination. With the current drive of global COVID-19 immunization, this case highlights the importance of documenting vaccination history at the time of scanning to avoid false-positive results.
引用
- Ahmed N, Muzaffar S, Binns C, et al. COVID-19 Vaccination Manifesting as Incidental Lymph Nodal Uptake on 18F-FDG PET/CT. Clin Nucl Med. 2021. PMID: 33661193. doi:10.1097/RLU.0000000000003635
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。